Kirwin Patrick D.'s Form 4 filing
ProMIS Neurosciences Inc.PMN · filed Aug 18, 2022
- Accession no.
- 0001062993-22-018369
- Filed
- Aug 18, 2022
- Trade date
- Aug 17, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. Open-market purchases total $23.7K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kirwin Patrick D.CIK 0001927062 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 17, 2022 | Common Shares | PPurchaseAcquired | +4,000 | $5.92F1 | +$23,680 | 41,983 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The purchase price of CAD$7.65 has been converted to USD based on the Bank of Canada exchange rate on August 17, 2022 of CAD$1.2912= US$1.00.
Referenced by the price of 1 transaction in Table I.